Skip to main content
. 2013 Sep 17;48(8):650–655. doi: 10.1310/hpj4808-650

Table 1.

Summary of therapeutic options in the management of cannabinoid hyperemesis syndrome

Agent Indication and dosing Clinical outcome
IV Sodium chloride 0.9% Hydration
1-2 L bolus and then 150-200 mL/h infusion for 24 to 48 hours
Demonstrated symptom improvement in case reports4,18

Morphine Pain
4 mg IV as needed
Demonstrated pain control in case reports18

Acetaminophen Headache
650 mg as needed
Demonstrated headache relief in case reports18

Lorazepam Nausea/vomiting
1 mg IV x 1 OR
1 mg IV every 4 h as needed
Demonstrated symptom improvement in case reports18,19

Chlorpromazine Hiccups
25 mg IV every 4 h as needed
Demonstrated symptom improvement in case reports18

Note: CHS = cannabinoid hyperemesis syndrome; h = hour; IV = intravenous.